Neogenomics Lab Services
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The Department of Veterans Affairs (VA), specifically the Network Contracting Office (NCO) 21, has awarded a Firm Fixed-Price Indefinite Delivery/Indefinite Quantity (IDIQ) contract to NeoGenomics Laboratories, Inc. for Specialized Oncology and Molecular Laboratory Testing Services. This sole source award, valued at $5,000,000.00, will support Veterans within the VA Central California Healthcare System (VACCHCS) catchment area in Fresno, CA.
Scope of Work
NeoGenomics Laboratories, Inc. will provide as-needed oncology and molecular laboratory testing services. This includes a comprehensive range of tests such as Neo Comprehensive – Myeloid Disorders, NEO RAS/RAF Panel Tissue, NeoTYPE disease-specific profiles, NeoTYPE cancer profiles (including NGS panels for solid tumors and hematologic malignancies), FISH assays, Immunochemistry (IHC) antibodies and stains, molecular diagnostic tests (single gene assays, targeted/comprehensive panels, flow cytometry), Cytogenetics, and Liquid Biopsy molecular testing. The services also encompass packaging, pick up, and transport of specimens to NeoGenomics laboratories.
Contract & Timeline
- Award Number: 36C26126D0032
- Contract Type: Firm Fixed-Price Indefinite Delivery/Indefinite Quantity (IDIQ)
- Awarded Contractor: NeoGenomics Laboratories, Inc. (UEI: ML9LFC5CK7K9)
- Award Amount: $5,000,000.00 (Overall IDIQ Ceiling)
- Period of Performance: Five ordering periods from April 26, 2026, through April 25, 2031, with an option to extend services for up to six months.
- Set-Aside: Sole Source (Other Than Full and Open Competition)
- Award Date: April 24, 2026
- Place of Performance: Fresno, CA, United States
- Product Service Code: Q301 (Reference Laboratory Testing)
Justification
This acquisition was conducted as a sole source to NeoGenomics Laboratories, Inc. due to the proprietary nature of their NeoTYPE cancer profiles and associated lab tests. Market research indicated no other sources could provide these specific tests, and no Small Disabled Veteran Owned Small Business/Veteran Owned Small Business vendors were identified. The VA determined NeoGenomics to be the only source capable of meeting the requirement. The Contracting Officer ensured the final contract price was fair and reasonable.